NBTX Nanobiotix SA: ערך חשבונאי למניה

Nanobiotix S.A. (NBTX) is developing a biotechnological foundation to enhance the impact of radiation therapy by supplying nanoparticles for regular use to medical centers. The business relies on an established transportation system for radiopharmaceuticals through a network of specialized counterparties, which maintains profitability at -0.76. Its status as a leading European innovator and alliances with pharma behemoths attract capital. The price history of NBTX shares is presented below.

Nanobiotix S.A. (NBTX) is developing the high-tech nanomedicine sector, leveraging a stable staff of specialized researchers in France and the US. Investments in human capital directly determine the volume of net assets that form the calculation base for this metric. This indicator reflects the portion of equity attributable to a single share, determining the intrinsic value of the business. An increase in this value reduces the company's financial risks. The trend in reported book value per share helps investors assess real capitalization without market distortions.